(Q24245649)

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

The effects of oral propranolol and metoprolol on lung function and exercise performance in chronic airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Reversibility of bronchospasm in airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Metoprolol, a Β-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Dose-response relationship of the ?-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Propranolol and pindolol in chronic obstructive lung disease (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Effect of beta-blocker therapy on functional status in patients with heart failure--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Quality of life in treatment of hypertension. A metaanalysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Beta-blockers and depression. Evidence against an association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Pooling research results: benefits and limitations of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Clinical relevance of pharmacokinetic differences between beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Diabetic patients and beta-blockers after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Treatment of hyperthyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Early beta-blocker therapy for acute myocardial infarction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

A meta-analysis of perioperative beta blockade: what is the actual risk reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Choice of drug treatment for elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Required beta blocker profile in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Cardioselective beta-blockers for reversible airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Beta blockade during and after myocardial infarction: an overview of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Effects of Labetalol in Hypertensive Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

National patterns and predictors of beta-blocker use in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Suppression of atrial ectopy with intravenous metoprolol in chronic obstructive pulmonary disease patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Respiratory function in the elderly and the effects of beta blockade

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Effects of oxprenolol on the airways of normal and bronchitic subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Physician use of beta-adrenergic blocking therapy: a changing perspective

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Effect of intravenous metoprolol on reversible obstructive airways disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

[Effect of various beta-receptor blockaders on ventilation in patients with obstructive respiratory tract disease. Comparative studies]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

[On the effect of adrenergic beta-receptor-blocking agents on the ventilatory function in obstructive lung diseases]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Bronchial response to beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

β-Adrenoceptor Blockade and Pulmonary Function in Patients Suffering from Chronic Obstructive Lung Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Beta adrenoceptor antagonists and respiratory disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

A comparison of celiprolol and chlorthalidone in hypertensive patients with reversible bronchial obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Beta1-blocker (practolol) and exercise in patients with chronic obstructive lung disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Treatment of hypertension in mild asthmatic patients with atenolol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

A comparison of oral metoprolol and propranolol in patients with chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

Use of β-Adrenoreceptor Blockers in Combination with β-Stimulators in Patients with Obstructive Lung Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003566.PUB2

7 January 2021

10.1002/14651858.CD003566.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_w7aknyircbhldm7miixih74dzq

987427

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w7aknyircbhldm7miixih74dzq

24 November 2022

mapped directly with Wikidata item

987427

1 reference

Consolidated OpenCitations Corpus – April 2017

https://api.fatcat.wiki/v0/release/w7aknyircbhldm7miixih74dzq

1 reference

24 November 2022

mapped directly with Wikidata item

PubMed ID

16235327

1 reference

Consolidated OpenCitations Corpus – April 2017